Champions Oncology Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingApr 2025Apr 2024Apr 2023Apr 2022Apr 2021
Valuation Ratios
P/E Ratio20.85189.51396.90
Forward P/E119.1742.9577.31
P/S Ratio1.721.311.242.123.50
P/B Ratio25.98-34.6514.3911.4219.34
Price/Tangible Book28.5115.5111.8520.26
Price/FCF14.0160.6425.25
Price/OCF13.2716.8015.98
PEG Ratio6.096.09
Enterprise Value Ratios
EV/Revenue1.781.381.192.133.48
EV/EBITDA15.6546.9092.05
EV/EBIT20.94172.63389.82
EV/FCF14.5158.1225.48
Profitability & Returns
Return on Equity (ROE)5.03%-5.32%-0.78%0.07%0.06%
Return on Assets (ROA)0.10%-0.14%-0.08%0.01%0.01%
Return on Invested Capital (ROIC)3.01%-2.30%-0.70%0.05%0.05%
Return on Capital Employed (ROCE)0.57%-1.51%-0.35%0.03%0.02%
Leverage & Solvency Ratios
Debt/Equity1.68-3.901.851.041.29
Debt/EBITDA0.762.293.37
Debt/FCF0.907.822.30
Liquidity Ratios
Current Ratio0.940.630.901.131.13
Quick Ratio0.880.560.831.061.04
Efficiency Ratios
Asset Turnover1.951.661.551.561.70
Yield & Distribution Ratios
Earnings Yield0.05%-0.11%-0.08%0.01%0.00%
FCF Yield0.07%-0.11%0.02%0.04%-0.03%
Buyback Yield-0.05%0.00%0.04%0.03%-0.23%